Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis

Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about American Vanguard Corporation
American Vanguard Corporation News
American Vanguard Corporation Quantitative Score

About American Vanguard Corporation
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
American Vanguard Corporation Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
American Vanguard Corporation Financials
Table Compare
Compare AVD metrics with: | |||
---|---|---|---|
Earnings & Growth | AVD | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | AVD | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | AVD | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | AVD | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
American Vanguard Corporation Income
American Vanguard Corporation Balance Sheet
American Vanguard Corporation Cash Flow
American Vanguard Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Strong Buy |
Return on Equity | Strong Sell |
Return on Assets | Strong Sell |
Debt/Equity Ratio | Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Strong Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
American Vanguard Corporation Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 0.1200 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-07-10 | 0.03 | Quarterly |
2024-04-10 | 0.03 | Quarterly |
2024-01-12 | 0.03 | Quarterly |
2023-10-06 | 0.03 | Quarterly |
2023-07-14 | 0.03 | Quarterly |
Historical Market Cap
Shares Outstanding
American Vanguard Corporation Executives
Name | Role |
---|---|
Mr. David T. Johnson C.F.A. | Chief Financial Officer |
Mr. Timothy J. Donnelly Esq. | Chief Information Officer, General Counsel & Secretary |
Mr. Anthony Young | Director of Investor Relations |
Mr. Douglas A. Kaye III CPA | Chief Executive Officer |
Ms. Shirin Khrosavi | Chief Human Resource Officer |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. David T. Johnson C.F.A. | Chief Financial Officer | Male | 1957 | 508.07K |
Mr. Timothy J. Donnelly Esq. | Chief Information Officer, General Counsel & Secretary | Male | 1960 | 398.24K |
Mr. Anthony Young | Director of Investor Relations | Male | -- | |
Mr. Douglas A. Kaye III CPA | Chief Executive Officer | Male | -- | |
Ms. Shirin Khrosavi | Chief Human Resource Officer | Female | -- |
American Vanguard Corporation Insider Trades
Date | 13 Mar |
Name | Straley Jared |
Role | SVP, Operations & Supply Chain |
Transaction | Disposed |
Type | |
Shares | 0 |
Date | 13 Mar |
Name | Gilliam Nolteanous |
Role | SVP, Manufacturing |
Transaction | Disposed |
Type | |
Shares | 0 |
Date | 22 Jan |
Name | Gilliam Nolteanous |
Role | SVP, Manufacturing |
Transaction | Disposed |
Type | |
Shares | 2191 |
Date | 13 Mar |
Name | DiPaola Michael Joseph |
Role | SVP, Strategy and R&D |
Transaction | Disposed |
Type | |
Shares | 0 |
Date | 11 Dec |
Name | Tiu de Mino Carmen |
Role | Director |
Transaction | Acquired |
Type | A-Award |
Shares | 6786 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
13 Mar | Straley Jared | SVP, Operations & Supply Chain | Disposed | 0 | |
13 Mar | Gilliam Nolteanous | SVP, Manufacturing | Disposed | 0 | |
22 Jan | Gilliam Nolteanous | SVP, Manufacturing | Disposed | 2191 | |
13 Mar | DiPaola Michael Joseph | SVP, Strategy and R&D | Disposed | 0 | |
11 Dec | Tiu de Mino Carmen | Director | Acquired | A-Award | 6786 |